AstraZeneca’s release Monday of encouraging data about its coronavirus vaccine from its U.S. trial raised hopes that the drug company could put a troubled rollout behind it. But just hours after its announcement, American officials issued an unusual statement expressing concern the company had included “outdated information” from its study and that it may have provided “an incomplete view of the efficacy data.”
Related posts
-
Jussie Smollett’s conviction in 2019 attack on himself is overturned
The Illinois Supreme Court on Thursday overturned actor Jussie Smollett’s conviction on charges that he staged... -
Catching up with recruiting for the Class of 2026 in the suburbs
With the IHSA football season coming to a close over the next couple of weeks, more... -
Silvy: I’ve said it before, I’ll say it again, Eberflus is not a good head coach
Matt Eberflus isn't a good head coach. You know it. I know it. Hopefully Ryan Poles...